Advisory Board

The board includes members from a range of life sciences companies and other academic institutions who work closely with WPI leadership to assess the university’s current programs and direct future life sciences initiatives.

Craig C. Mello Ph.D. (Chair)
Blais Professor of Molecular Medicine
Howard Hughes Medical Institute
University of Massachusetts Medical School
Program in Molecular Medicine

William C. Alexander ’81
Sr. Director/Team Leader
Global Contract Manufacturing
Pfizer, Inc.

Marni Hall Hallissey ’97, PhD, MPH
Director, Regulatory Science Staff 
Office of Surveillance & Epidemiology, CDER, FDA

Peter C. Isakson, Ph.D.
Director, MassBio Board 

Deborah Kochevar
Tufts Cummings School Veterinary Medicine

David G. LaPré ’73
VP Global Operations
Roche Diagnostics

Morey Kraus ’91
Chief Scientific Officer
PerkinElmer Life and Analytical Sciences, Inc.

Dr. Bruce D. Minsky ’77
Professor and Director, Clinical Research
Department of Radiation Oncology
The University of Texas MD Anderson Cancer Center

James T. Orcutt '79
President and Chief Executive Officer
New Brunswick Scientific Co.

Kevin O’Sullivan
President and CEO
Massachusetts Biomedical Initiatives

Catherine Prescott 
Founder and Director, Biolatris Ltd, UK
Biolatris Ltd
St John's Innovation Centre

Richard Resnick ’98
Chief Executive Officer
GenomeQuest, Inc.

Maintained by
Last modified: October 26, 2012 10:49:01